meclofenamic acid has been researched along with masoprocol in 11 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 9 (81.82) | 18.7374 |
| 1990's | 1 (9.09) | 18.2507 |
| 2000's | 1 (9.09) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
| Conroy, MC; Kennedy, JA; Thueson, DO | 1 |
| Ehrhart, IC; el-Kashef, HA; Hofman, WF | 1 |
| Caldwell, DR; Centifanto, YM; Yates, F | 1 |
| Beckman, BS; Fisher, JW; King, L; Mason-Garcia, M; Nystuen, L | 1 |
| Barton, BE; Wheeler, L; WoldeMussie, E | 1 |
| Beckman, B; Nystuen, L | 1 |
| Harper, MJ; Herlihy, JT; Johns, A | 1 |
| Flynn, JT; Gee, MH; Havill, AM; Perkowski, SZ; Tahamont, MV | 1 |
| Flynn, JT; Gee, MH; Havill, AM; Perkowski, SZ | 1 |
| Chen, BN; McLennan, PL; Menadue, MF; Oliver, JR; Rayner, TE | 1 |
11 other study(ies) available for meclofenamic acid and masoprocol
| Article | Year |
|---|---|
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Differential inhibition of histamine release from human basophils induced by antigen, anti-IgE or N-formyl-L-methionyl-L-leucyl-L-phenylalanine.
Topics: 4,5-Dihydro-1-(3-(trifluoromethyl)phenyl)-1H-pyrazol-3-amine; Antibodies, Anti-Idiotypic; Antigens; Basophils; Catechols; Cells, Cultured; Chromones; Histamine Release; Humans; Immunoglobulin E; Indoles; Indomethacin; Masoprocol; Meclofenamic Acid; N-Formylmethionine Leucyl-Phenylalanine; Oxazoles; Pyrazoles; Receptors, Fc; Receptors, Formyl Peptide; Receptors, IgE; Receptors, Immunologic; Tetrazoles | 1985 |
Effect of a lipoxygenase inhibitor on vasoconstriction in dog lung.
Topics: Acetylcholine; Animals; Blood Pressure; Catechols; Cyclooxygenase Inhibitors; Dogs; Female; Lipoxygenase Inhibitors; Lung; Male; Masoprocol; Meclofenamic Acid; Norepinephrine; ortho-Aminobenzoates; Pulmonary Circulation; Serotonin; Vascular Resistance; Vasoconstriction | 1989 |
The effect of modulating the synthesis of arachidonic acid cascade products on HSV lesion recurrence.
Topics: Animals; Arachidonic Acid; Arachidonic Acids; Betamethasone; Chlorpromazine; Dexamethasone; Ear; Herpes Simplex; Masoprocol; Meclofenamic Acid; Mice; Recurrence | 1987 |
The action of erythropoietin is mediated by lipoxygenase metabolites in murine fetal liver cells.
Topics: 12-Hydroxy-5,8,10,14-eicosatetraenoic Acid; 4,5-Dihydro-1-(3-(trifluoromethyl)phenyl)-1H-pyrazol-3-amine; Animals; Arachidonic Acid; Arachidonic Acids; Aspirin; Butylated Hydroxyanisole; Erythropoiesis; Erythropoietin; Hydroxyeicosatetraenoic Acids; Liver; Masoprocol; Meclofenamic Acid; Mice; Phosphatidylinositols; Pyrazoles | 1987 |
The role of arachidonic acid metabolism in IL-3-induced proliferation.
Topics: 4,5-Dihydro-1-(3-(trifluoromethyl)phenyl)-1H-pyrazol-3-amine; Anti-Inflammatory Agents, Non-Steroidal; Arachidonic Acids; Aspirin; Cell Division; Cell Line; Indomethacin; Interleukin-3; Lipoxygenase Inhibitors; Masoprocol; Meclofenamic Acid; Propionates; Pyrazoles | 1988 |
Comparative effects of inhibitors of arachidonic acid metabolism on erythropoiesis.
Topics: 4,5-Dihydro-1-(3-(trifluoromethyl)phenyl)-1H-pyrazol-3-amine; Animals; Arachidonic Acid; Arachidonic Acids; Aspirin; Butylated Hydroxyanisole; Cyclooxygenase Inhibitors; Erythropoiesis; Hematopoietic Stem Cells; Lipoxygenase Inhibitors; Masoprocol; Meclofenamic Acid; Mice; Pyrazoles | 1988 |
Modulation of vascular smooth muscle sensitivity by preload and eicosanoid synthesis inhibition.
Topics: 5,8,11,14-Eicosatetraynoic Acid; Animals; Dose-Response Relationship, Drug; Eicosanoic Acids; Female; Indomethacin; Masoprocol; Meclofenamic Acid; Methacrylates; Muscle, Smooth, Vascular; Phenylephrine; Potassium Chloride; Quinacrine; Rabbits; Serotonin | 1987 |
Eicosanoids, leukocytes and lung injury.
Topics: 6-Ketoprostaglandin F1 alpha; Anaphylaxis; Animals; Blood Pressure; Catechols; Complement Activation; Complement System Proteins; Cyclooxygenase Inhibitors; Free Radicals; Leukocyte Count; Lipoxygenase Inhibitors; Lymphatic System; Masoprocol; Meclofenamic Acid; Oxygen; Superoxide Dismutase; Thromboxane B2 | 1985 |
Role of prostaglandins and leukotrienes in complement-initiated lung vascular injury.
Topics: Animals; Catechols; Complement Activation; Epoprostenol; Hypertension, Pulmonary; Hypoxia; Leukocytes; Leukotriene B4; Masoprocol; Meclofenamic Acid; ortho-Aminobenzoates; Oxygenases; Prostaglandins; Pulmonary Circulation; Sheep; Zymosan | 1983 |
Effect of ischaemia and role of eicosanoids in release of atrial natriuretic factor from rat heart.
Topics: Animals; Atrial Natriuretic Factor; Disease Models, Animal; Diterpenes; Eicosanoids; Ginkgolides; Heart Rate; Lactones; Male; Masoprocol; Meclofenamic Acid; Myocardial Contraction; Myocardial Ischemia; Myocardium; Perfusion; Platelet Activating Factor; Rats; Rats, Inbred Strains; Secretory Rate | 1993 |